AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2011
Aug 12, 2011
34301_dirs_2011-08-12_0ac93145-f8c0-4541-93a4-85d009f90338.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-02-28
Reporting Person: HEDRICK MARC H (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-12 | Common Stock | P | 100 | $3.17 | Acquired | 4100 | Indirect |
| 2011-08-12 | Common Stock | P | 500 | $3.1793 | Acquired | 4600 | Indirect |
| 2011-08-12 | Common Stock | P | 100 | $3.1891 | Acquired | 4700 | Indirect |
| 2011-08-12 | Common Stock | P | 200 | $3.189 | Acquired | 4900 | Indirect |
| 2011-08-12 | Common Stock | P | 1600 | $3.19 | Acquired | 6500 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7800 | Indirect |
| Common Stock | 485088 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26